View source for Bacterial meningitis (IDSA 2004)


Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. '''Practice guidelines for the management of bacterial meningitis'''. ''Clin Infect Dis''. 2004 Nov 1;39(9):1267-84. Epub 2004 Oct 6. doi: [https://doi.org/10.1086/425368 10.1086/425368]


==Table 4: Empiric Treatment==

{| class="wikitable"
!Population
!Common pathogens
!Antimicrobial therapy
|-
! colspan="3" |Age
|-
|&lt;1 month
|[[Group B streptococcus]], [[Escherichia coli]], [[Listeria]], [[Klebsiella]]
|amp + cefotax, or<br />amp + AG
|-
|1-23 months
|[[Streptococcus pneumoniae]], [[Neisseria meningitidis]], [[Group B streptococcus]], [[Haemophilus influenzae]], [[Escherichia coli]]
|vanco + 3G ceph
|-
|2-50 years
|[[Neisseria meningitidis]], [[Streptococcus pneumoniae]]
|vanco + 3G ceph
|-
|&gt;50 years
|[[Streptococcus pneumoniae]], [[Neisseria meningitidis]], [[Listeria]], [[Gram-negative bacilli]]
|vanco + 3G ceph + amp
|-
! colspan="3" |Head trauma
|-
|Basilar skull fracture
|[[Streptococcus pneumoniae]], [[Haemophilus influenzae]], [[GAS]]
|vanco + 3G ceph
|-
|Penetrating trauma
|[[Staphylococcus aureus]], [[coagulase-negative staphylococci]], [[Gram-negative bacilli]]
|vanco + cefep, or<br />vanco + ceftaz, or<br />vanco + mero
|-
|Post-neurosurgery
|[[Gram-negative bacilli]], [[Staphylococcus aureus]], [[coagulase-negative staphylococci]]
|vanco + cefep, or<br />vanco + ceftaz, or<br />vanco + mero
|-
|CSF shunt
|[[Coagulase-negative staphylococci]], [[Staphylococcus aureus]], [[Gram-negative bacilli]], [[Cutibacterium acnes]]
|vanco + cefep, or<br />vanco + ceftaz, or<br />vanco + mero
|}

[[Category:IDSA guidelines]]
[[Category:CNS infections]]